BioCentury | May 24, 2019
Finance

How Europe’s hotspots of innovation could fuel its rise as a global player in new modalities

...editing pioneer CRISPR Therapeutics AG and oncolytic virus plays PsiOxus Therapeutics Ltd. and Transgene S.A. SNIPR Biome ApS...
...plc (NASDAQ:ORTX), London, U.K. Pfizer Inc. (NYSE:PFE), New York, N.Y. PsiOxus Therapeutics Ltd., Abingdon, U.K. SNIPR Biome ApS...
BioCentury | May 16, 2019
Emerging Company Profile

SNIPR: Turning CRISPR into a microbiome suicide

...four years, plus a Phase I trial for one of them in 2021. COMPANY PROFILE SNIPR Biome ApS...
...Biosciences Inc., Morrisville, N.C. Nemesis Bioscience Ltd., Cambridge, U.K. Technical University of Denmark, Copenhagen, Denmark SNIPR Biome ApS...
...Copenhagen, Denmark Statens Serum Institut, Copenhagen, Denmark Targets Cas3 - CRISPR-associated helicase Cas3 Mark Zipkin, Staff Writer SNIPR Biome ApS Statens...
BioCentury | Mar 15, 2019
Finance

SNIPR targets the microbiome

...and autoimmune company. Lundbeckfonden Emerge's Christian Elling told BioCentury the early stage investment firm seeded SNIPR Biome ApS...
...board, along with Wellington's Regina Hodits and North-East Family Office's Ulrik Vejlsgaard. Mark Zipkin, Staff Writer LSP Lundbeckfond Emerge CRISPR microbiome SNIPR Biome ApS...
BioCentury | Mar 15, 2019
Product Development

The microbiome universe in two maps

...View, Calif. Second Genome Inc., South San Francisco, Calif. Seres Therapeutics Inc. (NASDAQ:MCRB), Cambridge, Mass. SNIPR Biome ApS...
...Pharmaceuticals A/S Genetic Analysis A/S MaaT Pharma S.A. Osel Inc. Second Genome Inc. Seres Therapeutics Inc. Symbiotix Biotherapies Inc. Synlogic Inc. Vedanta Biosciences Inc. SNIPR Biome ApS...
BioCentury | Mar 11, 2019
Financial News

$50M series A for CRISPR microbiome play SNIPR Biome

...LSP. Other new investors included the Danish family office North-East Family Office and Wellington Partners. SNIPR Biome ApS...
...to selectively target bacterial pathogens (see "Cutting Through Resistance" ). Stephen Hansen, Associate Editor CRISPR-associated protein 9 (Cas9) CRISPR microbiome SNIPR Biome ApS...
Items per page:
1 - 5 of 5
BioCentury | May 24, 2019
Finance

How Europe’s hotspots of innovation could fuel its rise as a global player in new modalities

...editing pioneer CRISPR Therapeutics AG and oncolytic virus plays PsiOxus Therapeutics Ltd. and Transgene S.A. SNIPR Biome ApS...
...plc (NASDAQ:ORTX), London, U.K. Pfizer Inc. (NYSE:PFE), New York, N.Y. PsiOxus Therapeutics Ltd., Abingdon, U.K. SNIPR Biome ApS...
BioCentury | May 16, 2019
Emerging Company Profile

SNIPR: Turning CRISPR into a microbiome suicide

...four years, plus a Phase I trial for one of them in 2021. COMPANY PROFILE SNIPR Biome ApS...
...Biosciences Inc., Morrisville, N.C. Nemesis Bioscience Ltd., Cambridge, U.K. Technical University of Denmark, Copenhagen, Denmark SNIPR Biome ApS...
...Copenhagen, Denmark Statens Serum Institut, Copenhagen, Denmark Targets Cas3 - CRISPR-associated helicase Cas3 Mark Zipkin, Staff Writer SNIPR Biome ApS Statens...
BioCentury | Mar 15, 2019
Finance

SNIPR targets the microbiome

...and autoimmune company. Lundbeckfonden Emerge's Christian Elling told BioCentury the early stage investment firm seeded SNIPR Biome ApS...
...board, along with Wellington's Regina Hodits and North-East Family Office's Ulrik Vejlsgaard. Mark Zipkin, Staff Writer LSP Lundbeckfond Emerge CRISPR microbiome SNIPR Biome ApS...
BioCentury | Mar 15, 2019
Product Development

The microbiome universe in two maps

...View, Calif. Second Genome Inc., South San Francisco, Calif. Seres Therapeutics Inc. (NASDAQ:MCRB), Cambridge, Mass. SNIPR Biome ApS...
...Pharmaceuticals A/S Genetic Analysis A/S MaaT Pharma S.A. Osel Inc. Second Genome Inc. Seres Therapeutics Inc. Symbiotix Biotherapies Inc. Synlogic Inc. Vedanta Biosciences Inc. SNIPR Biome ApS...
BioCentury | Mar 11, 2019
Financial News

$50M series A for CRISPR microbiome play SNIPR Biome

...LSP. Other new investors included the Danish family office North-East Family Office and Wellington Partners. SNIPR Biome ApS...
...to selectively target bacterial pathogens (see "Cutting Through Resistance" ). Stephen Hansen, Associate Editor CRISPR-associated protein 9 (Cas9) CRISPR microbiome SNIPR Biome ApS...
Items per page:
1 - 5 of 5